CNR Institutional Research Information System

ESPOSITO, CARLA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 875
NA - Nord America 507
EU - Europa 350
SA - Sud America 229
AF - Africa 25
OC - Oceania 3
Totale 1.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 460
SG - Singapore 400
BR - Brasile 191
IT - Italia 160
CN - Cina 158
HK - Hong Kong 106
VN - Vietnam 103
FR - Francia 52
NL - Olanda 47
JP - Giappone 25
CA - Canada 24
KR - Corea 24
DE - Germania 22
AR - Argentina 21
MX - Messico 14
FI - Finlandia 11
GB - Regno Unito 10
IN - India 10
BD - Bangladesh 9
IQ - Iraq 8
ZA - Sudafrica 7
AT - Austria 6
IE - Irlanda 6
AL - Albania 5
ES - Italia 5
IL - Israele 5
EC - Ecuador 4
EG - Egitto 4
MA - Marocco 4
VE - Venezuela 4
CO - Colombia 3
PK - Pakistan 3
PL - Polonia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HN - Honduras 2
ID - Indonesia 2
IR - Iran 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UA - Ucraina 2
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
ZM - Zambia 1
Totale 1.989
Salva come PNG Salva come JPEG
Città #
Singapore 237
Santa Clara 131
Hong Kong 104
San Jose 45
Lauterbourg 44
Beijing 43
Ho Chi Minh City 40
Los Angeles 35
Milan 34
Ashburn 31
Marigliano 31
Hefei 30
Seoul 23
São Paulo 23
Tokyo 23
Hanoi 21
Naples 21
New York 14
Montreal 12
Frankfurt am Main 10
Helsinki 10
Dallas 9
Rio de Janeiro 6
Casandrino 5
Da Nang 5
Dublin 5
Düsseldorf 5
Johannesburg 5
Vienna 5
Biên Hòa 4
Buffalo 4
Council Bluffs 4
Houston 4
Toledo 4
Ascoli Piceno 3
Atlanta 3
Avellino 3
Brasília 3
Brooklyn 3
Cairo 3
Curitiba 3
Genoa 3
Guarulhos 3
Manaus 3
Orem 3
Palermo 3
Plano 3
São Gonçalo 3
São José dos Pinhais 3
Tashkent 3
Toronto 3
Alegrete 2
Almirante Tamandaré 2
Amsterdam 2
Auckland 2
Baghdad 2
Barretos 2
Belo Horizonte 2
Bengaluru 2
Berlin 2
Boydton 2
Caivano 2
Campinas 2
Campos dos Goytacazes 2
Cape Town 2
Casablanca 2
Chaguanas 2
Chennai 2
Chicago 2
Colombo 2
Cà Mau 2
Dhaka 2
Duque de Caxias 2
Falkenstein 2
Feira de Santana 2
Guayaquil 2
Haiphong 2
Hải Dương 2
Ilhéus 2
London 2
Medina de Pomar 2
Mexico City 2
Miami 2
Minamishinagawa 2
Nairobi 2
New Delhi 2
Padua 2
Pavia 2
Philadelphia 2
Phoenix 2
Phủ Lý 2
Prague 2
Rio Grande 2
Rosario 2
Sala Baganza 2
Salvador 2
San Francisco 2
Sant'Arpino 2
Santa Maria 2
Somma Vesuviana 2
Totale 1.176
Salva come PNG Salva come JPEG
Nome #
New aptamer-based approaches for the targeting of cancer associated fibroblast in NSCLC 84
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 82
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 79
Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity 76
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 70
Selection of a nuclease‐resistant rna aptamer targeting cd19 69
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts 67
Emerging therapeutic RNAs for the targeting of cancer associated fibroblasts 63
Stick-based methods for aptamer-mediated siRNA targeted delivery 62
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 60
The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses 60
Advances in mRNA non-viral delivery approaches 54
Selection of RNA aptamers targeting hypoxia in cancer 53
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 53
Advances in Oligonucleotide Aptamers for NSCLC Targeting 53
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 53
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 51
Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer 50
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 50
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 48
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 45
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells 45
Identification of an interfering ligand aptamer for EphB2/3 receptors 44
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 44
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 43
Aptamer chimeras for therapeutic delivery: The challenging perspectives 43
Nucleic acids delivering nucleic acids 41
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 40
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 39
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 38
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 36
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 34
Aptamer-miRNA conjugates for cancer cell-targeted delivery 32
cleic acids in human glioma treatment: innovative approaches and recent results 30
Coupling aptamers to short interfering RNAs as therapeutics 28
Aptamer-mediated targeted delivery of therapeutics: An update 28
A Trojan horse for human immunodeficiency virus 27
New insight into clinical development of nucleic acid aptamers. 27
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 27
Recent advance in biosensors for microRNAs detection in cancer 26
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 25
Developing aptamers by cell-based SELEX 25
Aptamer cell-based selection: Overview and advances 24
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 23
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 22
Ex.50.T aptamer impairs tumor–stroma cross-talk in breast cancer by targeting gremlin-1 21
Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation 19
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 18
Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice 16
Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity 4
Totale 2.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.957
article - articoli 6.630
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 327
Totale 13.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 0 0 0 0 0 1 0 26 10
2024/2025843 9 1 55 26 126 58 87 91 45 61 155 129
2025/20261.259 40 92 140 195 223 87 181 53 62 99 55 32
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 2.151